Exploring 2017 Spring Symposium Oral Anticoagulants
Let's dive into the details surrounding 2017 Spring Symposium Oral Anticoagulants.
- Michael B. Bottorff, PharmD, discusses the appropriateness for drug monitoring and reversal agents with the use of direct
- Rajat Deo, MD, suggests the need for having reversal agents available for direct
- Visit: http://www.uctv.tv/) Steven R. Kayser, PharmD, Professor Emeritus, Department of Clinical Pharmacy, School of Pharmacy, ...
- Novel
- This presentation by Trevor Baglin was originally given at the ISTH 2013 Congress in Amsterdam. For more information and to ...
In-Depth Information on 2017 Spring Symposium Oral Anticoagulants
Dr. Kimberly Brayton M.D.: Ashwani Bedi, M.D., FHRS: Striving for Curative Atrial Fib Management Types of atrial fibrillation, update on This interview with Christopher B. Granger from Duke University Medical Centre, Durham, US discusses Trial to Improve ... Dr. Anisha Lakhani BCCFP Family Medicine
In this segment, Michael B. Bottorff, PharmD, remarks on the differentiation of direct
That wraps up our extensive overview of 2017 Spring Symposium Oral Anticoagulants.